In memoriam Rene Peslin Marchal F., Farre R. Eur Respir J 2010; 35: 715-716 | |
Lung cancer: multidisciplinary approach for management: Cell and Molecular Biology Assembly contribution to the celebration of 20 years of the ERS Brambilla E. Eur Respir J 2010; 35: 717-720 | |
Continuing medical education across Europe: the role of EBAP and the ERS in facing the challenges of life-long learning Gaga M., Severin T., Stevenson R. Eur Respir J 2010; 35: 721-722 | |
End-tidal CO2 for exclusion of suspected pulmonary embolism: a new partner for Wells? Bonderman D., Lang I. M. Eur Respir J 2010; 35: 723-724 | |
Ventilator-associated pneumonia: approaching the horizon Ewig S., Muller E., Hecker E. Eur Respir J 2010; 35: 725-727 | |
Idiopathic pulmonary fibrosis and pirfenidone Collard H. R. Eur Respir J 2010; 35: 728-729 | |
Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Said S. I., Hamidi S. A., Gonzalez Bosc L. Eur Respir J 2010; 35: 730-734 | |
Bedside end-tidal CO2 tension as a screening tool to exclude pulmonary embolism Hemnes A. R., Newman A. L., Rosenbaum B., Barrett T. W., Zhou C., Rice T. W., Newman J. H. Eur Respir J 2010; 35: 735-741 | |
School air quality related to dry cough, rhinitis and nasal patency in children Simoni M., Annesi-Maesano I., Sigsgaard T., Norback D., Wieslander G., Nystad W., Canciani M., Sestini P., Viegi G. Eur Respir J 2010; 35: 742-749 | |
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma Bhavsar P., Khorasani N., Hew M., Johnson M., Chung K. F. Eur Respir J 2010; 35: 750-756 | |
YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E Tang H., Fang Z., Sun Y., Li B., Shi Z., Chen J., Zhang T., Xiu Q. Eur Respir J 2010; 35: 757-760 | |
Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries Stanton N., Hood K., Kelly M. J., Nuttall J., Gillespie D., Verheij T., Little P., Godycki-Cwirko M., Goossens H., Butler C. C. Eur Respir J 2010; 35: 761-767 | |
Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate van Diemen C. C., Postma D. S., Aulchenko Y. S., Snijders P. J. L. M., Oostra B. A., van Duijn C. M., Boezen H. M. Eur Respir J 2010; 35: 768-775 | |
Calculating gambling odds and lung ages for smokers Hansen J. E., Sun X-G., Wasserman K. Eur Respir J 2010; 35: 776-780 | |
Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway Corcoran T. E., Thomas K. M., Myerburg M. M., Muthukrishnan A., Weber L., Frizzell R., Pilewski J. M. Eur Respir J 2010; 35: 781-786 | |
Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia Pifferi M., Bush A., Di Cicco M., Pradal U., Ragazzo V., Macchia P., Boner A. L. Eur Respir J 2010; 35: 787-794 | |
Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients Mounier R., Adrie C., Francais A., Garrouste-Orgeas M., Cheval C., Allaouchiche B., Jamali S., Dinh-Xuan A. T., Goldgran-Toledano D., Cohen Y., Azoulay E., Timsit J-F., Ricard J-D., on behalf of the OUTCOMEREA Study Group Eur Respir J 2010; 35: 795-804 | |
C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia Hillas G., Vassilakopoulos T., Plantza P., Rasidakis A., Bakakos P. Eur Respir J 2010; 35: 805-811 | |
No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 m Dehnert C., Luks A. M., Schendler G., Menold E., Berger M. M., Mairbaurl H., Faoro V., Bailey D. M., Castell C., Hahn G., Vock P., Swenson E. R., Bartsch P. Eur Respir J 2010; 35: 812-820 | |
Pirfenidone in idiopathic pulmonary fibrosis Taniguchi H., Ebina M., Kondoh Y., Ogura T., Azuma A., Suga M., Taguchi Y., Takahashi H., Nakata K., Sato A., Takeuchi M., Raghu G., Kudoh S., Nukiwa T., the Pirfenidone Clinical Study Group in Japan Eur Respir J 2010; 35: 821-829 | |
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis Zappala C. J., Latsi P. I., Nicholson A. G., Colby T. V., Cramer D., Renzoni E. A., Hansell D. M., du Bois R. M., Wells A. U. Eur Respir J 2010; 35: 830-836 | |
Nasopharyngoscopic evaluation of oral appliance therapy for obstructive sleep apnoea Chan A. S. L., Lee R. W. W., Srinivasan V. K., Darendeliler M. A., Grunstein R. R., Cistulli P. A. Eur Respir J 2010; 35: 836-842 | |
Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea Kim J., Bhattacharjee R., Snow A. B., Capdevila O. S., Kheirandish-Gozal L., Gozal D. Eur Respir J 2010; 35: 843-850 | |
Nested PCR in lung tissue for diagnosis of pulmonary tuberculosis Park J. S., Kang Y. A., Kwon S. Y., Yoon H. I., Chung J-H., Lee C-T., Lee J. H. Eur Respir J 2010; 35: 851-857 | |
Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis Lorgelly P. K., Atkinson M., Lakhanpaul M., Smyth A. R., Vyas H., Weston V., Stephenson T. Eur Respir J 2010; 35: 858-864 | |
Lung function and bronchodilator response in 4-year-old children with different wheezing phenotypes Oostveen E., Dom S., Desager K., Hagendorens M., De Backer W., Weyler J. Eur Respir J 2010; 35: 865-872 | |
New concepts for expressing forced expiratory volume in 1 s arising from survival analysis Miller M. R., Pedersen O. F. Eur Respir J 2010; 35: 873-882 | |
Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism Wong C. K., Cao J., Yin Y. B., Lam C. W. K. Eur Respir J 2010; 35: 883-893 | |
Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing Heijink I. H., Brandenburg S. M., Noordhoek J. A., Postma D. S., Slebos D-J., van Oosterhout A. J. M. Eur Respir J 2010; 35: 894-903 | |
Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats Chen Y., Hanaoka M., Droma Y., Chen P., Voelkel N. F., Kubo K. Eur Respir J 2010; 35: 904-912 | |
Cognitive function in COPD Dodd J. W., Getov S. V., Jones P. W. Eur Respir J 2010; 35: 913-922 | |
Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension Arends S. J., Damoiseaux J., Duijvestijn A., Debrus-Palmans L., Boomars K., Broers B., Cohen Tervaert J. W., van Paassen P. Eur Respir J 2010; 35: 923-925 | |
Levels of soluble human leukocyte antigen-G are increased in asthmatic airways White S. R., Loisel D. A., McConville J. F., Stern R., Tu Y., Marroquin B. A., Noth I., Ober C. Eur Respir J 2010; 35: 925-927 | |
Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation Sandhu G., Dasgupta R., Ranade A., Baskin M. Eur Respir J 2010; 35: 927-929 | |
Unusual treatment of patent foramen ovale after pneumonectomy Welvaart W. N., Becker A., Marcus J. T., Vonk-Noordegraaf A., Oosterhuis J. W. A., Paul M. A. Eur Respir J 2010; 35: 929-931 | |
How to treat children's pneumonia: a complex problem Don M., Korppi M. Eur Respir J 2010; 35: 932-933 | |
Endocrinological derangement in COPD Andreas S. Eur Respir J 2010; 35: 933 | |
From the authors: Laghi F., Adiguzel N., Tobin M. J. Eur Respir J 2010; 35: 934 | |
Pre-operative evaluation of lung function test results Houltz B., Olofson J., Bake B. Eur Respir J 2010; 35: 935 | |
Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective Udwadia Z. F., Sen T., Moharil G. Eur Respir J 2010; 35: 936-938 | |
From the authors: Sotgiu G., Centis R., Lange C., D'Ambrosio L., Guenther G., Spanevello A., Migliori G. B. Eur Respir J 2010; 35: 938-940 | |
The online Cough Clinic Widdicombe J., Fontana G. Eur Respir J 2010; 35: 940-941 | |
To the Editors: Leconte S., Degryse J. Eur Respir J 2010; 35: 941 | |